$SNX

HUME RICHARD T sold $25K of SNX

HUME RICHARD T sold 88 shares of TD SYNNEX CORP (SNX) at $285.26 on 2026-06-02 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · HUME RICHARD T
Published Jun 3, 2026, 9:21 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jun 3, 2026, 9:23 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefInsider activity
Primary signal
$SNX
Neutral
medium confidence
Mentioned
$SNX
Relevance
6/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$SNXNeutralLow
01

Why it matters

The disclosure provides incremental sentiment information but no new business or earnings catalyst.

02

Market read

Traders may monitor for insider-trading trends, but this specific sale is unlikely to drive a material repricing.

03

What to watch

The filing does not indicate why the sale occurred; traders should check for patterning across prior Form 4s and whether other insiders are buying/selling around the same window.

Relevance 6/10Novelty 6/10Timing: Filed June 3; sale executed June 2 (open-market, 10b5-1 plan).

Background

This is a SEC Form 4 insider transaction (director selling) for TD SYNNEX, executed under a pre-arranged Rule 10b5-1 plan.

Company-level read

Ticker impact

$SNXNeutralMedium confidence
Context

Director Hume Richard T sold 88 shares of TD SYNNEX (SNX) via an open-market transaction under a 10b5-1 plan, disclosed on Form 4.

Expected impact

Low likelihood of sustained price impact; any reaction is likely muted and short-lived.

Evidence & confidence

The filing is an ownership-change disclosure with a stated 10b5-1 plan, and the share count/value ($25.1k) is small relative to typical company market caps.

Market effects

Minimal; this is company-specific insider activity with no stated operational/financial change.

None indicated.

None indicated.

Counterpoint

Even with a 10b5-1 plan, repeated insider sales can coincide with periods of elevated valuation or risk management rather than negative fundamentals.

Key entities

  • TD SYNNEX CORP

    Subject of the Form 4 insider transaction; director sold shares under a 10b5-1 plan.

  • HUME RICHARD T

    Director who executed the open-market sale (88 shares) on June 2, disclosed June 3.

Related articles

$SNXHigh

TD SYNNEX CORP (SNX): Results of Operations and Financial Condition

TD SYNNEX CORP (SNX) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 ex991-fy26q2pressrelease.htm EX-99.1 Document Exhibit 99.1 TD SYNNEX Reports Record Fiscal 2026 Second Quarter Results • Revenue of $19.6 billion, an increase of 31.0% year over year, 29.1% in constant currency (1) , and significantly above the high end of our outlook.